Intake Forms for Sleep Medicine Clinics: Sleep History Assessment, Daytime Symptoms, and Polysomnography Preparation
Sleep medicine occupies a unique position within the clinical landscape. Unlike most medical specialties where the patient is awake and symptomatic during the encounter, sleep disorders manifest during a state the patient cannot directly observe. A patient with obstructive sleep apnea may have no conscious memory of the hundreds of respiratory events that fragment their sleep each night. Someone with periodic limb movement disorder might be entirely unaware of the repetitive leg jerks that are driving their bed partner to a separate bedroom. This fundamental challenge makes the intake process in a sleep medicine clinic far more than an administrative formality. It is the clinician's primary tool for reconstructing a narrative that the patient themselves may not fully understand.
A well-designed sleep medicine intake form does three things simultaneously. It gathers the subjective history that no overnight study can replace. It systematically screens for the conditions most commonly encountered in sleep medicine referrals so that nothing falls through the cracks. And it prepares both the patient and the clinical team for whatever diagnostic testing comes next, whether that is an in-lab polysomnogram, a home sleep apnea test, or an actigraphy study. Clinics that treat the intake form as an afterthought will find themselves spending the first twenty minutes of every consultation asking questions that could have been answered on paper in the waiting room, or worse, discovering halfway through a split-night study that the patient failed to mention the benzodiazepine they take every evening.
Sleep-Wake Schedule Documentation: The Foundation of Every Sleep Evaluation
The sleep-wake schedule is the single most informative section on any sleep medicine intake form, and it is routinely underestimated. Asking a patient what time they go to bed and what time they wake up is a start, but it barely scratches the surface. The form should distinguish between the time the patient gets into bed, the time they attempt to fall asleep, and their estimated sleep onset latency. These are three different data points, and conflating them leads to unreliable conclusions about whether a patient has a circadian rhythm disorder, behavioral insomnia, or something else entirely.
Equally important is capturing the difference between weekday and weekend schedules. A patient who reports going to bed at 11 PM and waking at 7 AM on weeknights but sleeping from 2 AM to noon on weekends is presenting a classic delayed sleep-wake phase pattern. If the intake form only has a single row for bedtime and wake time, that pattern disappears. The form should also capture napping behavior, including frequency, typical duration, whether naps are planned or involuntary, and what time of day they occur. An elderly patient who naps for ninety minutes every afternoon and then complains of difficulty falling asleep at 10 PM has a very different clinical picture than a twenty-five-year-old who falls asleep involuntarily during meetings despite sleeping eight hours the prior night.
For patients who work non-traditional hours, the sleep-wake schedule section needs to accommodate rotating shifts, permanent night shifts, and irregular schedules common among healthcare workers, pilots, long-haul truck drivers, and first responders. A standard bedtime-and-wake-time grid simply does not work for a nurse who alternates between day and night shifts every two weeks. The intake form should provide enough space to describe the shift pattern, indicate how many days off typically occur between shift changes, and capture whether the patient attempts to maintain their shift schedule on days off or reverts to a conventional sleep-wake cycle. This information is critical for distinguishing shift work disorder from an underlying sleep pathology that is merely unmasked by the schedule demands.
Validated Screening Instruments: Epworth Sleepiness Scale and STOP-BANG
Two validated instruments have become near-universal in sleep medicine intake workflows, and their inclusion on the intake form saves significant chair time during the consultation. The Epworth Sleepiness Scale asks the patient to rate, on a scale of zero to three, their likelihood of dozing in eight common situations: sitting and reading, watching television, sitting inactive in a public place, as a passenger in a car for an hour, lying down in the afternoon, sitting and talking to someone, sitting quietly after lunch without alcohol, and in a car while stopped in traffic. A total score above ten suggests excessive daytime sleepiness worthy of further investigation, and scores above fifteen indicate severe sleepiness that may warrant urgent evaluation, particularly for patients in safety-sensitive occupations.
The value of embedding the Epworth directly into the intake form rather than handing it out as a separate sheet cannot be overstated. When it appears in the flow of the overall intake, completion rates are significantly higher, and the clinician receives the score before the patient walks into the exam room. It also creates a documented baseline that can be compared to post-treatment scores when evaluating whether CPAP therapy, oral appliance therapy, or surgical intervention has meaningfully improved the patient's functional status. For clinics tracking outcomes data or participating in quality improvement programs, having the Epworth embedded in the intake record simplifies data extraction enormously.
The STOP-BANG questionnaire is the other workhorse screening tool for obstructive sleep apnea. Its eight binary questions cover snoring, tiredness during the daytime, observed apneas, high blood pressure, BMI above 35, age over 50, neck circumference greater than 40 centimeters, and male gender. A score of five or higher on the STOP-BANG carries a high sensitivity for moderate-to-severe OSA. While the STOP-BANG was originally validated as a preoperative screening tool for anesthesiology, it has been widely adopted in sleep medicine as a fast, reliable way to stratify referral urgency. Including it on the intake form means the physician can glance at the score and immediately gauge the pre-test probability before reviewing the rest of the history. For practices that triage new patient referrals based on clinical urgency, a high STOP-BANG score documented on the intake form can move a patient from a six-week wait to a next-available appointment.
Bed Partner Observations: The Witness Account That Changes Diagnoses
Sleep medicine is one of the few specialties where collateral history from a bed partner or household member can be more diagnostically valuable than the patient's own report. A patient with severe obstructive sleep apnea may describe their sleep as "fine" because they have no conscious awareness of the arousals that fragment it. Meanwhile, their spouse has been lying awake counting the seconds between gasps, watching for the chest to start moving again, and eventually retreating to the guest bedroom for their own survival. The intake form must create a structured pathway for capturing these observations.
The form should ask whether the patient shares a bed or bedroom with another person and, if so, whether that person has observed any of the following: loud or disruptive snoring, pauses in breathing or choking episodes, gasping or snorting sounds during sleep, excessive movement or restlessness, leg kicking or jerking, sleepwalking or other complex behaviors, and teeth grinding. Each of these observations points to a different differential diagnosis. Witnessed apneas with interposed snoring strongly suggest obstructive sleep apnea. Rhythmic leg movements every twenty to forty seconds point toward periodic limb movement disorder. Complex motor behaviors arising from deep sleep raise concern for REM sleep behavior disorder, a parasomnia that in older adults warrants screening for neurodegenerative conditions including Parkinson's disease and Lewy body dementia.
Importantly, the bed partner observation section should also capture the frequency and severity of these findings. There is a meaningful clinical difference between a bed partner who notices occasional snoring when the patient sleeps on their back after a glass of wine and one who describes nightly crescendo snoring with multiple witnessed apneas regardless of sleep position. If the form does not prompt for this level of detail, the clinician is left to extract it during the visit, consuming time that could have been spent on examination, counseling, or shared decision-making about diagnostic and treatment options.
Medication, Substance, and Dietary Assessment: What Patients Forget to Mention
Medications and substances interact with sleep architecture in ways that patients rarely connect to their sleep complaints. The intake form must go beyond the standard medication reconciliation that most clinics already perform and specifically ask about agents with known sleep effects. Caffeine consumption deserves its own dedicated section, capturing not just whether the patient drinks coffee but the total daily caffeine intake from all sources, including tea, soft drinks, energy drinks, pre-workout supplements, chocolate, and over-the-counter analgesics. The form should capture the timing of the last caffeinated beverage relative to the intended bedtime, because caffeine consumed even six hours before sleep has been shown to reduce total sleep time by more than an hour in controlled studies.
Alcohol use is equally important and equally undercaptured by generic intake forms. Alcohol is the most commonly used sleep aid in the general population, and many patients do not consider their nightly glass of wine to be medically relevant. The intake form should ask specifically about alcohol use within three hours of bedtime, the typical quantity, and whether the patient uses alcohol intentionally to facilitate sleep onset. Alcohol suppresses REM sleep in the first half of the night and produces rebound arousals in the second half. It also relaxes pharyngeal musculature and worsens obstructive sleep apnea. A patient whose apnea-hypopnea index is borderline on a night when they abstained from alcohol may have clinically significant disease on a typical evening at home.
The form should also ask about sedative-hypnotic use (both prescription and over-the-counter), including benzodiazepines, non-benzodiazepine receptor agonists such as zolpidem and eszopiclone, antihistamines, melatonin, cannabinoids, and herbal supplements including valerian and passionflower. Stimulant medications, including amphetamines and methylphenidate prescribed for ADHD, modafinil and armodafinil, and nicotine use, should be documented with their dosing schedule. All of these substances alter polysomnographic findings and must be accounted for when interpreting study results. If the sleep lab does not know that a patient takes clonazepam nightly, they may attribute the absence of periodic limb movements to a negative finding rather than recognizing that the medication suppressed them.
Comorbidity Screening: The Medical Context That Shapes Every Sleep Diagnosis
Sleep disorders do not occur in isolation. They cluster with cardiovascular disease, metabolic syndrome, mood disorders, and chronic pain conditions in patterns that are bidirectional and clinically significant. The intake form should screen for the comorbidities that most commonly intersect with sleep pathology, beginning with obesity. Recording height, weight, and calculated BMI is standard, but the form should also capture neck circumference, which is independently predictive of obstructive sleep apnea and is frequently omitted from general medical intake forms. A neck circumference greater than 17 inches in men or 16 inches in women substantially increases the pre-test probability of OSA regardless of overall body habitus.
Cardiovascular comorbidities deserve targeted questions. Hypertension, particularly resistant hypertension requiring three or more medications, is strongly associated with obstructive sleep apnea, and screening guidelines from the American Heart Association recommend that all patients with resistant hypertension be evaluated for OSA. Atrial fibrillation, heart failure, stroke, and pulmonary hypertension all have established relationships with sleep-disordered breathing. A patient referred for evaluation of snoring who also carries a diagnosis of atrial fibrillation and class III heart failure has a dramatically different risk profile than a young, otherwise healthy patient with the same complaint. The intake form should capture these diagnoses not through a free-text medical history field but through targeted checkboxes that the clinician can scan in seconds.
Depression, anxiety, and post-traumatic stress disorder are among the most common comorbidities in patients presenting to sleep medicine clinics, and the relationship is complex. Insomnia is both a symptom and a risk factor for major depression. Nightmares and sleep fragmentation are core features of PTSD. Anxiety disorders frequently present with prolonged sleep onset latency that patients describe as insomnia. The intake form should include at minimum a two-item depression screen (the PHQ-2) and direct questions about nightmares, intrusive thoughts at bedtime, and hypervigilance in the sleep environment. Gastroesophageal reflux disease warrants a separate mention because nocturnal reflux can mimic or exacerbate sleep apnea symptoms, and patients may not volunteer this information unless directly asked. A few targeted questions about heartburn, regurgitation, and the need to sleep with the head of bed elevated can prevent a missed diagnosis.
Prior Sleep Studies and Treatment History: Building on What Has Already Been Tried
A surprising number of patients presenting to a new sleep medicine practice have already undergone one or more polysomnograms, home sleep apnea tests, or MSLT studies at other facilities. The intake form should ask directly whether the patient has previously had any sleep testing, where it was performed, the approximate date, and whether the patient received a diagnosis or was told the study was normal. This information accomplishes two things. First, it prevents unnecessary repeat testing when a recent, high-quality study is available and can be obtained from the referring facility. Second, it identifies patients who have already been diagnosed with a sleep disorder and are seeking care because their current treatment is inadequate, a very different clinical scenario from a new diagnostic evaluation.
For patients with a history of sleep apnea, the form should capture their treatment history in detail. This means asking about CPAP or BiPAP use, including the prescribed pressure settings if known, the type of mask interface (nasal, nasal pillows, full face), the approximate date therapy was initiated, current usage patterns, and the reasons for any discontinuation. A patient who abandoned CPAP after two weeks because the mask leaked is a candidate for mask refitting and desensitization counseling. A patient who used CPAP faithfully for three years at a pressure of 12 cm of water but now has a residual AHI of 8 on download may need a pressure adjustment, a switch to auto-titrating PAP, or evaluation for a component of central sleep apnea that has emerged during treatment. The form should also capture whether the patient has been evaluated for or treated with an oral appliance, hypoglossal nerve stimulation, or surgical interventions including uvulopalatopharyngoplasty, maxillomandibular advancement, or nasal surgery.
Patients presenting with insomnia should be asked about prior pharmacological and non-pharmacological treatments, with particular attention to whether they have attempted cognitive behavioral therapy for insomnia. CBT-I is the first-line treatment recommended by the American Academy of Sleep Medicine for chronic insomnia, and documenting whether it has been tried, partially completed, or never offered shapes the treatment plan substantially. Many patients have never heard of CBT-I and have been managed exclusively with sedative-hypnotic prescriptions for years. Others have attempted it through a digital platform but did not complete the full course. The intake form should capture this nuance rather than simply asking whether the patient has tried "therapy" for sleep.
Occupational Risk Assessment: When Sleepiness Becomes a Safety Issue
Few clinical scenarios in sleep medicine carry higher stakes than the patient whose untreated sleep disorder puts others at risk. Commercial motor vehicle operators, airline pilots, railroad engineers, heavy equipment operators, and law enforcement officers are among the occupational groups where excessive daytime sleepiness can have catastrophic consequences. The intake form should ask the patient's occupation, whether they hold a commercial driver's license, whether they operate heavy machinery or work at heights, and whether they have experienced drowsy driving or near-miss accidents. These questions are not optional. The Federal Motor Carrier Safety Administration requires that drivers with suspected or diagnosed moderate-to-severe sleep apnea demonstrate treatment compliance before medical certification, and the treating sleep physician is often the one certifying fitness for duty.
Shift workers present a distinct occupational concern. The intake form should capture the type of shift (fixed nights, rotating, twelve-hour, twenty-four-hour), the duration of the current shift pattern, and whether the patient has experienced workplace errors or accidents that they attribute to sleepiness or fatigue. Healthcare workers, particularly resident physicians, nurses working twelve-hour night shifts, and paramedics on twenty-four-hour rotations, are a population with both high rates of sleep disorders and high-consequence work environments. Documenting their shift pattern on intake allows the clinician to distinguish shift work disorder, which is driven by the schedule itself, from an independent sleep pathology that the shift schedule is exacerbating.
The form should also ask about driving habits more broadly. Drowsy driving is implicated in an estimated 100,000 crashes per year in the United States, and patients with untreated sleep apnea have a two- to three-fold increased risk of motor vehicle accidents compared to the general population. A direct question about whether the patient has fallen asleep at the wheel, drifted out of their lane due to sleepiness, or pulled over because they felt unable to continue driving safely provides information that many patients will not volunteer unless specifically prompted. Documenting this on the intake form not only informs clinical decision-making but also creates a medicolegal record that the clinician inquired about safety-relevant symptoms.
Characterizing Insomnia, Restless Legs, and Parasomnias: The Rest of the Differential
While obstructive sleep apnea drives the majority of referrals to sleep medicine clinics, insomnia, restless legs syndrome, periodic limb movement disorder, and the parasomnias collectively account for a substantial portion of clinical encounters. The intake form should screen for each of these conditions with enough specificity to guide the initial evaluation. For insomnia, the critical distinction is between sleep-onset insomnia and sleep-maintenance insomnia. A patient who lies awake for ninety minutes before falling asleep but then sleeps through the night has a different pathophysiology and treatment approach than a patient who falls asleep in five minutes but wakes at 3 AM and cannot return to sleep. The form should also ask about early morning awakening, whether the patient feels unrefreshed despite adequate sleep duration, and how many nights per week the insomnia occurs. Duration matters too: insomnia that has been present for less than three months is classified as acute and may resolve with sleep hygiene interventions, while chronic insomnia warrants a more structured treatment approach.
Restless legs syndrome has four essential diagnostic criteria, and the intake form can screen for all of them efficiently. The form should ask whether the patient experiences an urge to move the legs, often accompanied by uncomfortable sensations, that begins or worsens during periods of rest, is partially or completely relieved by movement, and occurs predominantly in the evening or at night. These questions map directly to the International Restless Legs Syndrome Study Group diagnostic criteria and, when all four are endorsed, have high diagnostic accuracy. The form should also capture whether the patient has a family history of restless legs, whether symptoms respond to iron supplementation, and whether the patient has been tested for iron deficiency, since serum ferritin levels below 50 to 75 micrograms per liter are associated with RLS severity and represent a modifiable treatment target.
Parasomnia history rounds out the screening portion of the intake form. The form should ask about sleepwalking, sleep talking, sleep eating, confusional arousals, night terrors, and whether the patient has ever injured themselves or a bed partner during sleep. For older adults, dream enactment behavior, defined as physically acting out vivid or violent dreams, is a red flag for REM sleep behavior disorder and should be asked about explicitly. RBD in isolation can precede the motor symptoms of Parkinson's disease, multiple system atrophy, or dementia with Lewy bodies by a decade or more, making its identification on an intake form a matter of long-term neurological significance. The intake form should capture whether dream enactment episodes have resulted in injury, their frequency, and whether the patient's dreams have become more vivid or violent over time.
Polysomnography Preparation: Setting Up a Successful Diagnostic Study
The intake form is the last opportunity to communicate with the patient before they arrive at the sleep lab, and the information gathered during intake directly affects the quality of the polysomnographic data. The form should capture any factors that might complicate sensor placement, including skin conditions, allergies to adhesives or electrode gel, facial hair that could interfere with mask fitting during a titration study, and claustrophobia or anxiety about sleeping in an unfamiliar environment. Patients who have had prior polysomnograms may have specific concerns based on that experience, such as difficulty sleeping with sensors attached or discomfort from a particular electrode site, and addressing these concerns proactively improves first-night study quality.
Medication instructions for the night of the study should be clarified during the intake process. The general principle is that patients should take their usual medications as prescribed so that the study reflects their typical sleep, but certain agents may need to be held or adjusted at the sleep physician's discretion. Documenting the patient's complete medication list on the intake form allows the ordering physician to provide specific instructions before study night rather than having the sleep technologist make ad hoc decisions at 9 PM when the patient arrives for their appointment. This is particularly important for patients taking REM-suppressing medications such as SSRIs and SNRIs, because if the purpose of the study includes evaluating for REM sleep behavior disorder or narcolepsy, the interpreting physician needs to know whether the medication was taken and might have altered REM architecture.
The intake form should also collect practical logistics that affect study execution. Does the patient require supplemental oxygen at night? Do they use a dental appliance, positional therapy device, or wedge pillow that they should bring to the lab? Is there a specific sleeping position they cannot tolerate due to pain or orthopedic limitations? Does the patient have mobility limitations that affect their ability to transfer to and from the bed or use the restroom independently during the night? A sleep technologist who knows in advance that a patient uses a wheelchair, requires a hospital bed with rails, or cannot lie flat due to severe GERD or heart failure can prepare the room accordingly rather than improvising at the start of the study. These logistical details rarely make it into the referral note from the primary care physician, and the intake form is the mechanism for capturing them systematically.
Finally, the intake form should establish the patient's expectations and goals for the evaluation. Some patients arrive at a sleep medicine clinic hoping to avoid CPAP at all costs. Others are desperate for any treatment that will stop the snoring that is threatening their marriage. Still others have been sent by a cardiologist or endocrinologist and do not fully understand why sleep testing has been recommended. Understanding the patient's perspective before the consultation allows the clinician to tailor the discussion appropriately, address misconceptions early, and engage the patient as a partner in their care rather than a passive recipient of a diagnostic workup they did not request. A single open-ended field at the end of the intake form asking the patient to describe their primary sleep concern and what they hope to achieve from the evaluation can be remarkably informative and takes almost no space on the page.
Streamline Your Sleep Medicine Intake Process
Templateez offers professionally designed, fillable PDF intake forms and client questionnaires built for healthcare and specialty practices. Each form is structured to capture the clinical detail your team needs while keeping the patient experience smooth and efficient. Browse our full catalog or save with a category bundle.